SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Bishop who started this subject12/5/2000 1:36:56 PM
From: Harry_Behemoth  Read Replies (1) of 150070
 
This one is on the Pink Sheets;

Nutraceutical Clinical Laboratories International, Inc. Announces the Signing of a $11.6 Million Contract
TUESDAY, DECEMBER 05, 2000 11:09 AM
- BusinessWire

ST. PETERSBURG, Fla., Dec 5, 2000 (BUSINESS:NCCL) announced the signing of its fourth major contract in as many weeks.

Nutraceutical Clinical Laboratories International, Inc. will manufacture more than 50 private label products for the Denver firm of "IntoBalance(TM)", currently marketing their products through its direct mail catalog. The $11.6 million contract calls for Nutraceutical Clinical Laboratories International, Inc. to have the exclusive manufacturing rights for its product line. IntoBalance(TM) plans a television, radio and Internet roll-out to the buying consumer beginning this month. IntoBalance(TM) will initiate the promotional roll-out with over 100,000 full color catalogs, television commercials, radio spots, and Internet promotions, valued in excess of $3 million.

The marketing program has been designed by some of the nation's top marketing experts and is believed to be as unique as the products to be offered. In addition, the products will be featured in "INTERNATIONAL FITNESS AND LONGEVITY JOURNAL", a national publication with an estimated readership of two million, which was acquired by Nutraceutical Clinical Laboratories International, Inc. in January of this year. The IntoBalance(TM) web site will feature a full line of consumer products and have e-commerce capabilities.

Nutraceutical Clinical Laboratories International, Inc.'s Chief Executive Officer, Paul Simmons, said today, "This contract, which combines a fulfillment center, will compliment the need for a call center and fulfillment services created by Longevity magazine." Within the next 60 days, Nutraceutical Clinical Laboratories International, Inc. plans to become a service provider (ISP) for its repeat customers.

Nutraceutical Clinical Laboratories International, Inc. trades on the OTC market under the symbol NCCL and can be found on the following servers -- nasdaq.com, cnbc.com, pinksheets.com, and otcquote.com. Nutraceutical Clinical Laboratories International, Inc.'s web site is www.nutradata.com.

Special note: Forward looking statements in this press release are made pursuant to the "safe-harbor" provisions of the Private Securities Litigation Act of 1995. Investors are cautioned that such forward looking statements involve risks and uncertainties, including without limitation, market acceptance of, demand for, the Company's products, manufacturing, development and distribution issues, product pricing, competition, technological changes and other risks not identified herein.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext